1. Introduction {#sec1}
===============

Hepatitis B is second hepatitis to be discovered and hence the name. The disease was discovered in 1947 \[[@bib1]\] and confirmed in 1965 \[[@bib2]\], and it is one of the leading causes of death in humans in the last two decades \[[@bib3]\]. The World Health Organization (WHO) reported that in 2015 there were 240 million people chronically infected with hepatitis B and more than 786,000 mortalities were attributed to it each year \[[@bib4]\]. Hepatitis B is caused by the hepatitis *B virus* (HBV) and can transmit through blood, semen, and other body fluids.

Into the new era of personalized treatment, there are growing evidences which show that the HBV genotype/subgenotype is associated with the HBeAg seroconversion, the severity of liver disease and the response rate to interferon-alpha therapy \[[@bib5], [@bib6], [@bib7]\]. As a result, the rational use of antivirus drugs and the precise prognosis is encouraged based on knowing the HBV specific genotyping and subgenotyping in hepatitis patients. However, the current HBV genotype/subgenotype correct classification research seems not so adequate.

The golden standard for classifying HBV used to be the sequence inter-group similarity of the entire viral genome. Okamoto et al. for the first time proposed that sequence divergence in the whole HBV genome exceeding 8% should be categorized as different HBV genotypes after analyzing 18 HBV isolates \[[@bib8]\]. Norder et al. then added 4% scalar at S-gene (codes for HBsAg) level in 1992 \[[@bib9]\]. These two standards constituted the definition of genotypes of HBV and are still used today \[[@bib10], [@bib11]\].

Thanks to the remarkable progress of molecular epidemiology research, more than 4,000 complete genomes of HBV have been investigated. There are ten genotypes (A-J) and more than 30 subgenotypes of human infected HBV that have been discovered and named \[[@bib7]\]. As a result, the genotyping methods developed by Okamoto et al. and Norder et al., are nowadays considered as controversial and antiquated because certain phylogenetic inference is lacking \[[@bib12]\]. The inconsistency between genotype/subgenotype identification and the clinical outcome had a direct impact on patients' antivirus therapy \[[@bib13], [@bib14]\].

Phylogeny estimation, a technique that has now proved to be the most efficient solution to analyze the divergence of homologous genes, was introduced when more and more researchers realized the defects of the present HBV genotyping system \[[@bib15], [@bib16]\]. This significant change in HBV classification is a benefit due to the rapid progress in molecular genetics and bioinformatics. However, the presence of recombination, which is the most significant force of virus evolution especially in high-speed evolved retroviruses, was always being incorrectly applied in phylogenetic analysis \[[@bib17]\]. Likewise, alignments including both recombinant and nonrecombinant cases, were used together for phylogeny reconstruction. But in fact, when evolutionary inferences were made from a data set with recombination taking place, the recombinant cases possessing breakpoints could induce an exponential growth of statistics in a test of selection pressure and then a mess of the estimation of substitution rate \[[@bib17], [@bib18]\]. The result is an ambiguous relationship that can be obtained between phylogenetic bisected clades which represented different monophyletic genotypes because of the recombinant ones' swaging between two or more ancestors. Therefore, Huson et al. believed the recombinant ones should be classified in a different system such as network reconstruction (which is not discussed in this study) \[[@bib19]\]. Usually, current HBV subgenotyping is directly using phylogenetic tree reconstruction no matter if recombinant occurred in that virus genome. As a result, the abusing of phylogeny has generated the current HBV subgenotype impreciseness. Therefore, in this study, viruses with recombination were carefully excluded, and a more robust HBV genotype/subgenotype frame has been established.

To upgrade the criterion of HBV genotyping/subgenotyping in this study, we reconstructed the phylogenetic tree of HBV genomes, using partitioned Bayesian model and over 4,000 DNA sequences. The partitioned Bayesian model is fully considered and weighted the subset-specific substitution rates of the coding sequence at genomic levels as the best-fit algorithm for phylogenetic analysis \[[@bib20]\]. The huge number of sequences applied constructed a comprehensive dataset of HBV genetics which can thoroughly and systematically investigate the current differentiation of HBV. Hence, in this study, a pure non-recombination phylogenetic tree was generated as a basis of HBV classification which could be used as a taxonomy guide. As a major upgrade, this work created a new insight into HBV genotyping and subgenotyping, which would further benefit hepatitis B diagnosis and treatment in the future.

2. Methods {#sec2}
==========

2.1. Sequence acquisition and processing {#sec2.1}
----------------------------------------

We acquired 4,429 complete genome sequences of HBV, including 4,186 from humans and 121 from non-human primates from GenBank. Each of the four genes (*S*, *C*, *P*, and *X*) was extracted using GenScalpel \[[@bib21]\] and aligned separately using MEGA 6.0 \[[@bib22]\]. The genetic distances between genotypes as well as subgenotypes were estimated under the Kimura 2-parameter model as implemented by MEGA 6.0 ([Table 1](#tbl1){ref-type="table"}).Table 1Gene/domain organization and analysis preferences in distance estimation.Table 1**Gene/domain organization:**Gene/DomainsFromToSitesCodon StartP/S/X-1 protein1253225321st siteX-2 protein253327472152nd siteC protein274832995521st site**Analysis Preferences/Distance Estimation:**Substitution TypeNucleotideModel/MethodKimura 2-parameter modelSubstitutions to Included: Transitions + TransversionsRates among SitesUniform ratesGaps/Missing Data TreatmentPairwise deletion

To optimize the following analyses, we reduced the number of sequences by group sequences into the operational taxonomic unit (OTU). We grouped the sequences using a minimum identity of 97% as the "radius" of an OTU, assuming that only sequences belonging to the same genotype/subgenotype would be grouped even in consideration of the possibility of recombination and thus would not affect the accuracy of our following analysis. This was implemented in USEARCH v8.1 \[[@bib23]\], and 600 OTUs were obtained and used in the subsequent analyses.

For better accuracy of phylogenetic interfaces, we detected and removed recombinant sequences using what we considered to be a conservative approach as implement in RDP4 \[[@bib24]\] accompanied by the use of SplitsTree 4 \[[@bib25]\]. RDP4 can determine approximate breakpoint positions and compare phylogenetic signals in opposite sites of recombination breakpoint. SplitsTree is used to analyze phylogeny that provides scenarios of reticulate evolution such as recombination networks. In RDP4, we detected recombination using six algorithms including 3Seq, Chimaera, Geneconv, MaxChi, RDP, and Siscan using the default settings. In case that recombination is observed in four of the six algorithms, we compared the phylogenetic positions of the major and the minor parent sequences estimated in UPGMA trees and inspected whether they were highly distinctive. We also used SplitsTree to determine the recombination network based on an equal angle algorithm to look for a potential recombinant sequence that was unaware by RDP4.

2.2. Phylogenetic inference {#sec2.2}
---------------------------

We estimated the phylogeny of HBV under Bayesian inference using BEAST v2.2.1 \[[@bib26]\]. First, we calculated the best-fit partitioning schemes under the Bayesian information criterion using PartitionFinder v1.1 \[[@bib27]\]. We defined the alignment of the complete HBV genome based on the physic positions of the four open reading frames and codon positions into 15 blocks. The gene P is partitioned at two isolated regions of the genome, so we estimated the partition schemes for each region separately. A total of 516 schemes were evaluated using the greedy algorithm. Finally, a partition scheme of 12 partitions was accepted ([Table 2](#tbl2){ref-type="table"}). A woolly monkey HBV genome (AF046996) was included in the alignment to root the tree. Each BEAST analysis used 12 partitions, one log-normal relaxed clock model, and a birth-death tree prior. We ran each analysis for 500 million generations and sampled every 50 000 generations. We repeated the analysis four times, calculated the effective sample size of each parameter using Tracer v1.6, and confirmed that all analyses reached similar posterior distribution. The maximum clade credibility tree and the posterior distribution for each node were calculated. Bayesian posterior probabilities (PP)≥0.95 were considered as strong supports for a given relationship \[[@bib28]\].Table 2Best partitioning scheme applied in the phylogenetic inference of the HBV genome.Table 2SubsetBest modelSubset partitionsSubset sites1SYM + GPPa_1st, PPa_2nd1-1063∖3, 2-1063∖32GTR + GPPa_3rd3-1063∖33SYM + GSP_1st1064-1744∖34TrNef + GSP_2nd1065-1744∖35SYM + GSP_3rd1066-1744∖36SYM + GCP_2nd, PPb_1st1745-2282∖3, 2749-3299∖37GTR + GCP_3rd, PPb_2nd1746-2282∖3, 2750-3299∖38SYM + GPPb_3rd1747-2282∖39GTR + GXP_1st2283-2747∖310SYM + GXP_2nd2284-2747∖311SYM + GXP_3rd2285-2747∖312SYM + GCP_1st2748-3299∖3

3. Results {#sec3}
==========

3.1. Phylogenetic relationship {#sec3.1}
------------------------------

Firstly, we removed recombinant sequences recognized by RDP4 and SplitsTree 4, and repeated the analyses three times. The numbers of sequences retained after each run of analyses were 577, 524, and 515, respectively. In total, we removed 85 recombinant OTU consensus sequences from the alignment and the remaining 516 sequences were sent to phylogenetic estimation.

Then, in the phylogenetic tree generated by 516 HBV sequences, eleven clades and two lineages were revealed corresponding to the ten human infected HBV genotypes (A to J) as well as three non-human primates HBV, while the genotypes H and J are represented by a single sequence each ([Fig. 1](#fig1){ref-type="fig"}). Genotypes F and H are sister to each other (PP = 1.0) and forms a basal monophyletic group (PP = 0.98). The genotypes A, B, C, and I also develop a strongly supported monophyletic clade (PP = 0.98), and the relationships among them are also well supported (PP ≥ 0.98). Phylogenetic relationships among the rest of the clades and lineages are not fully resolved (PP \< 0.85), while the genotype J is strongly supported as being embedded within the non-human primate HBV clades (PP ≥ 0.98).Fig. 1Phylogenetic reconstruction of HBV genomes. The values of Bayesian posterior probability are shown orderly at the nodes.Fig. 1

Based on highly supported phylogenetic relationships within the clades of genotypes, we recognized a series of subgenotypes. Notably, the subgenotypes of A3, D7, B9, etc. are highly incongruent from those reported by original reporters (Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}), while 26 stains failed to genotyping and 136 failed to subgenotyping ([Table 5](#tbl5){ref-type="table"}).Table 3The genotype, serotype, and geographical distribution of hepatitis *B virus* cases reported.Table 3GenotypeCasesSerotype^‡^Geographical distribution^§^This studyD4D(1), D4(3)*ayw*(4)Australia(3), Canada(3), Haiti(3), Papua New Guinea(1)D4D7D(3), D7(7), *Rec*(1)*ayw4*(1)Belgium(1), Central African Republic(1), Gabon(1), Tunisia(34)**[D6]{.ul}**D2D(8), D2(9)*adw3*(1), *ayw*(8), *ayw3*(5)Belgium(1), Greenland(1), India(1), Iran(1), Japan(1), Lebanon(3), Poland(3), Russia(1), Serbia(*add*), Spain(1), Taiwan(2), Turkey(2)D2D1D(20), D1(50), N/A(2)*ayw*(26), *ayw2*(13), *ayw3*(3)China(2), Greece(1), India(2), Indonesia(1), Iran(28), Italy(3), Japan(1), Lebanon(5), Mongolia(2), Pakistan(1), South Africa(1), Syria(10), Tunisia(4), Turkey(11)D1D?D(2)**×**D3/D6D(11), D3(6), D6(1)*adrq+*(1), *adw1*(1), *ayw*(7), *ayw2*(15), *ayw3*(7)Belarus(3), Belgium(8), Canada(3), China(3), Estonia(2), France(1), Haiti(1), India(15), Indonesia(5), Italy(4), Japan(1), Mongolia(3), Pakistan(1), Russia(1), Serbia(3), South Africa(6), Sweden(3), Turkey(2)**[D3]{.ul}**D5D(6), D5(1)*ayw*(1), *ayw2*(1), *ayw3*(11)India(22), Japan(1)D5EE(9)*ayw4*(4)Argentina(*add*), Cameroon(*add*), Central African Republic(*add*), Colombia(*add*), Ghana(1), Guinea(2), Namibia(1), Nigeria(5)EGG(2), *Rec*(1)*adw*(5), *adw2*(6)Argentina(2), Belgium(2), Brazil(4), France(2), Germany(2), Mexico(2), Netherlands(1), Thailand(1), USA(8),G*non-human primates*(26)JJ(1)*ayw*(1)Japan(1)JC2*-part1*B2(1), C(33), C1(2), C2(95), N/A(17)*adr*(22), *adrq-*(1), *adrq+*(99), *adw*(2), *adw1*(10), *adw2*(2)Bolivia(1), China(101), Hong Kong(2), Japan(27), Malaysia(4), South Korea(7), Taiwan(6)C2C2-*part2*C(4), C2(3), N/A(1)*adr*(2), *adrq+*(6), *adw2*(1)China(8), Hong Kong(2), Japan(6), Malaysia(1), South Korea(1), Taiwan(5)**[C3]{.ul}**C1-*part1*C(10), C1(22), N/A(1), *Rec*(4)*adr*(11), *adrq+*(6), *adw*(1)Belgium(1), Cambodia(1), China(8), Hong Kong(7), India(2), Indonesia(2), Japan(1), Malaysia(8), Myanmar(1), Taiwan(1), Thailand(8), Tunisia(1), Viet Nam(3)C1C1-*part2*C(1), C1(1), C2(2)*adrq+*(3)China(4), Malaysia(2)**[C1]{.ul}**C?C(5), C2(1)*adr*(2), *adrq-*(1), *adrq+*(13)China(16), Indonesia(1), Japan(1), Taiwan(1)**[C4]{.ul}**C6/C7C(2), C6(6), C7(1)*adr*(4), *ayw*(2)Australia(2), Indonesia(17), South Korea(1)**[C6]{.ul}**C5C5(4)*adw*(3), *adw2*(3)Indonesia(3), Malaysia(3), Philippines(3), Thailand(2)C5A1A(5), A1(14), N/A(3)*adw*(4), *adw2*(13), *ayw*(1), *ayw2*(1)Argentina(*add*), Bangladesh(1), Belgium(1), Central African Republic(*add*), Colombia(*add*), Congo(*add*), Haiti(5), India(3), Malaysia(*add*), Nepal(*add*), Philippines(*add*), Rwanda(*add*), Somalia(*add*), South Africa(11), Tanzania(1), Zimbabwe(add)A1A3A(1), A3(4)*ayw*(1)Cameroon(6), Gabon(3), Nigeria(2)A3A5A5(5)Cameroon(2), Haiti(21), Nigeria(3)**[A3]{.ul}**A7A7(6)Cameroon(10)**[A3]{.ul}**A3?A(1), A3(2)Cameroon(1), Gabon(1), Guinea(1), Mali(1)**[A3]{.ul}**A2/A6A(3), A2(6)*adw*(2), *adw2*(4), *ayw1*(3)Argentina(add), Australia(add), Belarus(add), Belgium(3), Canada(add), Estonia(add), France(add), Germany(2), Italy(1), Japan(add), Latvia(add), Poland(2), Russia(add), South Africa(add), Tunisia(1), USA(add), Uzbekistan(add)**[A2]{.ul}**II(1); N/A(3)*ayw*(1), *ayw1*(1)China(2), India(1), Laos(1)**I**B1B(2), B1(8)*adw*(3)Japan(33)B1B2B(9), B2(9), N/A(1), *Rec*(2)adrq+(3), *adw*(4), *adw1*(15), *adw2*(6), *ayw*(1), *ayw2*(1)China(12), Hong Kong(1), Japan(*add*), Malaysia(8), South Korea(*add*), Taiwan(*add*), Thailand(*add*), Viet Nam(*add*)B2B4B4(1)*ayw1*(2)Malaysia(1), Viet Nam(3)B4B5B5(3)*ayw*(3), *ayw1*(2)Malaysia(2), Philippines(5)**[B3]{.ul}**B3/B7/B8B(6), B3(7), B7(1), B8(2), C1(1), N/A(1), *Rec*(4)*adw*(4), *ayw*(2), *ayw1*(8)China(8), Indonesia(36), Malaysia(18), Philippines(1), Taiwan(4), Thailand(1)**[B3]{.ul}**B9B9(1)*ayw*(1), *ayw1*(1)China(1), Indonesia(7), Malaysia(2), Philippines(1)**[B3]{.ul}**B6B(2), B6(3)Canada(23), Greenland(2)**[B5]{.ul}**F3F(1), F3(2)*adw4*(2)Colombia(3), Venezuela(16)F3F4F4(2), *Rec(2)adw4*(14)Argentina(18), Bolivia(7), Brazil(2)F4F2F2(2)*adw4*(4)Nicaragua(1), Venezuela(7)F2F1F1(3)*adw4*(29)Argentina(16), Chile(18), Costa Rica(2), El Salvador(2), Ireland(1), Japan(1), Peru(2), USA: Alaska(9)F1HH(1)*adw4*(3), *adw*(7)Argentina(2), Japan(5), Mexico(9), Nicaragua(2), Thailand(1), USA(4)H[^3][^4]Table 4516 sequences in [Fig. 1](#fig1){ref-type="fig"}.Table 4CladeSequencesD4AB033559, FJ692533, GQ922004, GQ922005D7AM494716, GU177079, FJ904397, FJ904428, FJ904439, FJ904436, FJ904414, FJ349207, FJ904400, FJ904425, FJ904433D2AB188241, GQ477453, GQ477456, AB205128, AY090452, AY341335, JF754621, FJ349206, GQ477454, JN642148, JN642162, JN642163, JN664944, GU456635, AB555500, AB555501, JN792905D1AB188244, JN040787, AB270540, J904431, EU787440, GQ358159, EF103281, FJ904429, JF754626, JN040782, JN642133, JF754588, JF754622, JN642157, GU456684, JF754606, X59795, AB270549, FJ904426, GU456677, DQ486023, X80924, EU787438, JN642136, JN040781, JN642128, JF754609, JF754617, JF754612, JN257195, GU456665, GU456674, GU456676, GU456678, JN040766, JN257214, GU456669, JN040760, JN040762, JN040768, JN040773, AB583681, GQ184322, AY236163, JN257211, N257212, JN257213, DQ304548, GQ183466, JN040752, JN040772, AY741798, GU456638, JN040818, GU456642, GU456644, GU456645, GU456647, GU456651, JN040820, JN040800, JN040812, JF754602, JF754632, JF754586, JF754611, JN257154, JN257158, JN257217, JN257207, JN642154, JF754608D?FJ904422, JN664931D3/6AB188243, AB270537, AY236164, DQ329356, DQ486025, FJ349211, FJ349221, JF440005, FJ349213, GQ922000, JF754625, AB493848, EU921419, DQ315777, FJ562338, EU414142, EU939680, AB270538D5DQ315780, JN664929, GQ205381, JN664933, JN664934, JN664947, JN664923EAB219533, DQ060829, GQ161805, EU239220, GQ161774, AB219534, HM363611, HM363583, FN545824GAB056516, AB375169, DQ078791*non-human primates*AB037928, AY781185, AY781181, AY781183, AJ131574, AY077736, HQ603058, HQ603059, FM209516, HQ603080, AJ131571, HQ603077, AY330915, HQ603081, FM209512, FM209513, AY330917, FM209514, AF242586, D00220, JQ664505, AJ131567, AM117396, AY330911, FJ798098JAB486012C2-*part1*AB042285, AB205124, AB471851, D16665, AB176642, GQ475343, AB367405, GQ475326, AB367392, AB111112, AB111113, AB300369, D23682, JF828906, JF828912, AB195948, AB367421, AB367413, AB367429, AY641563, EF137803, GQ475342, AB697510, AB298721, M38636, GQ475335, EU939547, FJ562320, FJ787490, EU939552, FJ386617, JQ040135, FJ386625, AB113877, B485809, EU589344, EU589346, FJ899767, FJ787487, FJ787488, EU939536, FJ386626, FJ899783, EU939539, GQ227695, J562273, GQ377563, FJ899775, B113878, AB250109, AB367420, AB367425, FJ899788, GQ372968, EU589340, FJ562317, FJ386622, EU939617, FJ386611, JF436919, AB367415, DQ993690, HM011479, AY206378, EU919165, HM011481, EU660225, EU660226, EU881995, EU919166, DQ089794, GQ475353, EU306717, EU306718, FJ032347, FJ032348, FJ787469, JQ040129, FJ899794, EU547562, FJ562326, JX504540, FJ562255, EU554540, EU939601, FJ899768, EU939668, JQ027322, Y18858, AY057947, EU560438, EU560439, EU939641, EU939643, EU787444, EU939541, EU939558, AB365452, FJ032343, EU939564, EU939657, FJ562271, FJ787463, FJ562249, AF384372, EU560441, EU939655, EU919169, FJ386677, AY220700, EU717213, FJ386594, EU939602, AB367428, FJ386580, FJ386651, FJ562336, AF182804, EU871974, EU717217, EU871988, EU939574, EU939596, EU939659, FJ899770, JX026885, FJ562339, D23681, DQ986375, AF458665, EU796070, FJ787440, DQ089800, FJ787483, JQ040159, EU939568, FJ787456, FJ386640, FJ562248, FJ386612, FJ562302, EU939554, EU939580, FJ562241, HQ638218, FJ386586, FJ562245C2-*part2*AB115417, AB115418, AY167091, EU564820, FJ562298, JQ027332, DQ089802, EU882006C1-*part1*AB074047, GQ924619, GQ924623, GQ924642, EU306686, JQ801522, AB117758, JQ801508, JN827425, JQ801518, DQ315782, JQ027326, JQ429078, EU498227, HM011495, GQ358154, FJ361772, AB112063, AY167092, FJ904423, JQ027314, DQ089762, DQ089768, JQ027324, AY217376, AY217378, DQ089772, EU305542, AY217372, HM011486, DQ089790, DQ089776, DQ089785, DQ089780, EU872005, JQ040133, GQ377631C1-*part2*EU547559, FJ562300, GQ377555, JX504537C?AB675675, AY206374, EU939624, AY206376, EU939625, GQ358158C6/C7AB048705, AB493838, AB493843, AP011103, AP011102, GQ358157, AP011106, AP011108, GU721029C5AP011100, GQ924657, GQ924620, JN827415A1AB116082, AF418685, AF418689, FJ692566, AF418683, FJ692570, FJ692583, FJ692586, AB246317, JN182323, JN182326, AF297623, GU563545, AF297625, HQ646555, HQ646556, FJ692573, AY233275, AF297621, U87742, AY233290, AY233279A3AM184125, AB194952, HM363613, FN545825A5FJ692555, FJ692599, FJ692609, FJ692608, FJ692611A7FN545829, FN545840, FN545832, FN545839, FN545833, FN545837A3?GQ161813, FJ349296, FN545826A2/A6AF143304, AF143306, DQ298163, GQ477469, EU859908, EU859927, GQ477500, FJ904411, EU859952IEU835240, FJ023667, FR714496, FR714499B1AB073847, AB300371, AB073849, AB073856, AB642101, AB073858, AB302095, AB106884, AB073853, AB642093B2AF461360, HM011504, AJ131133, GU815689, DQ995802, HM011475, JQ027329, EU939636, HM011482, FJ386648, EU579441, EU939675, JQ027313, EU547563, HM011466, FJ518811, EU522066, GQ924630, DQ995804, FJ899790, EU939661B4GQ924626B5AB219427, AB241116, GQ924640B3/B7/B8AB219430, GQ924617, JQ027328, JQ429079, EU660230, HM011467, HM011469, JQ027311, GQ358140, GQ924628, GQ924639, JQ027316, GQ924641, DQ361535, EU331000, GQ358144, GQ358145, HM011487, GQ924621, GQ924635, AY800392, GQ924656B9GQ358150B6AB287320, DQ463799, DQ463802, JN792899, JN792901F3AB036905, FJ589068, DQ899150F4AB214516, JQ272888, AB365453, HE981178F2DQ899142, DQ899144F1EU670261, HM590472, FJ589065HAB275308Table 5Statistics of [Fig. 1](#fig1){ref-type="fig"}.Table 5CladeNumber of SequencesFailed to genotypingFailed to subgenotypingInconsistent subgenotyping within cladeD441D71131(D/E *Rec*)D2178D172220D?22D3/618111(D6)D576E9G31(G/C *Rec*)J1C2-*part1*14817333(B2, C1×2)C2-*part2*814C1-*part1*371104(C/A *Rec* ×2, C/A/B *Rec*, C/G *Rec*)C1-*part2*412(C2×2)C?65C6/C7921(C7)C54A12235A351A55A76A3?31A2/A693I4B1102B221192(B/C *Rec* ×2)B41B53B3/B7/B822164(B/C *Rec* ×4)B91B652F331F442(F/D *Rec*, F/G *Rec*)F22F13H1[^5]

In order to calibrate the HBV genotype/subgenotype nomenclature and calculate the genetic distances within/between groups, each of HBV genotypes was further analyzed as follows.

3.2. Genotypes of HBV {#sec3.2}
---------------------

***Genotype A*.** 50 species were recognized as in genotype A and used to assign into seven subgenotypes (A1-A7, [Fig. 2](#fig2){ref-type="fig"}A). While A1 (as known as Aa) and A2 (Ae) are widely distributed in Africa/Asia and Europe \[[@bib29]\], respectively, A3/A5/A7/A3? were only reported in one case study each ([Table 6](#tbl6){ref-type="table"}). Geographically, A3/A5/A7/A3? were from five countries in west-central Africa as well as Haiti, a state in which 90% of the population are descendants of African slaves ([Table 3](#tbl3){ref-type="table"}) \[[@bib30]\]. The estimated genetic distances between these subgenotypes were only 0.0380--0.0435 ([Table 7](#tbl7){ref-type="table"}).Fig. 2Phylogeny of genotype A/B/C/D of HBV. A: Genotype A (upper left); B: Genotype B (upper right); C: Genotype C (lower left); D: Genotype D (lower right). The values of Bayesian posterior probability are shown orderly at the nodes. Nodes of PP \> 0.95, which considered as a robust monophyletic group were shown in filled circles. Subgenotype names were shown after the tree while old classification with grey alphabets and new classification with colorful alphabets.Fig. 2Table 6The major reports of subgenotype A3-A7.Table 6SubgenotypeReferencesA3Kurbanov F, Tanaka Y, Fujiwara K, *et al.* J Gen Virol. 2005; 86(Pt 7):2047--56.A4Olinger CM, Venard V, Njayou M, *et al.* J Gen Virol 2006; 87:1163--1173.A5Andernach IE, Nolte C, Pape JW, *et al.* Emerg Infect Dis 2009; 15:1222--1228.A6Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, *et al.* J Clin Virol 2010; 47:93--96.A7Hübschen JM, Mbah PO, Forbi JC, *et al.* Clin Microbiol Infect 2011; 17:88--94.Table 7Estimates of evolutionary divergence over sequences pairs between tentative Genotype A.Table 7A1A3A5A7A3?A2A6A1A30.0509A50.04790.0380A70.05510.04260.0406A3?0.04960.04170.03950.0435A20.05580.05410.05030.05740.0517A60.04980.04660.04510.04950.04470.0494

For showing a robust phylogenetic relationship, we adjusted the branches composed by A3/A5/A7/A3? to new subgenotype A3, and A2/A6 to new subgenotype A2 ([Table 3](#tbl3){ref-type="table"} and [Fig. 2](#fig2){ref-type="fig"}A). Subgenotype A1 kept the original name. Based on the new subgenotype, evolutionary divergences in Genotype A were analyzed ([Table 8](#tbl8){ref-type="table"}), while their epidemiological distribution was also described ([Fig. 3](#fig3){ref-type="fig"}).Table 8Estimates of evolutionary divergence between subgenotypes of HBV genotype A.Table 8A1A2A3A1A20.0538A30.05120.0514Fig. 3Geographical distributions of HBV Genotype A.Fig. 3

***Genotype B.*** There used to be nine subgenotypes (B1--B9) reported in genotype B, which consists of 63 sequences ([Fig. 2](#fig2){ref-type="fig"}B). As a genotype typically distributed in Asia (B1 or Bj in Japan, B2 or Ba in Asia) \[[@bib31]\], only B6 were sporadically found in Canada \[[@bib32]\] and Greenland \[[@bib33]\] ([Table 3](#tbl3){ref-type="table"}). Further analysis showed that B5, B7--B9 possess a short distance with B3 and each other (0.0275--0.0398, [Table 9](#tbl9){ref-type="table"}).Table 9Estimates of evolutionary divergence over sequences pairs between tentative Genotype B.Table 9B1B2B4B5B3B7B8B9B6B1B20.0548B40.05720.0455B50.06860.05520.0508B30.07060.05730.05360.0398B70.06760.05380.04820.03440.0314B80.06670.05440.04860.03670.03630.0305B90.06500.05230.04730.03160.03450.02750.0310B60.06460.07250.07160.06360.06400.05650.06330.0579

Along with the phylogenetic relationship showed in [Fig. 2](#fig2){ref-type="fig"}B and considering the distribution information \[[@bib34], [@bib35]\], we integrated subclade B5, B3/B7/B8, and B9 into new subgenotype B3. Subgenotype B1, B2 and B4 kept their original name. And subgenotype B6 was then numbered to B5 sequentially. So far, genotype B was divided into five new subgenotypes (B1--B5, [Table 10](#tbl10){ref-type="table"}), of which B1 is only distributed in Japan, B2--B4 are mainly distributed in Southeast Asia, and B5 is sporadically distributed in Canada and Greenland ([Fig. 4](#fig4){ref-type="fig"}).Table 10Estimates of evolutionary divergence between subgenotypes of HBV genotype B.Table 10B1B2B3B4B5B1B20.0548B30.06950.0564B40.05730.04740.0535B50.06460.07250.06310.0719Fig. 4Geographical distributions of HBV Genotype B.Fig. 4

***Genotype C***. As the biggest group of HBV, genotype C was mainly reported in Asia \[[@bib36]\] and believed seven subgenotypes (C1--C7, [Fig. 2](#fig2){ref-type="fig"}C). Interestingly, three of five strains that apart from Asia ([Table 3](#tbl3){ref-type="table"}) were proved to be caused by transmission from Japanese immigrants \[[@bib37], [@bib38]\]. Therefore, we believed that genotype C is predominantly found in Asian populations.

Combining evolutionary distances between groups ([Table 11](#tbl11){ref-type="table"}), geographical distribution ([Table 3](#tbl3){ref-type="table"}) and robust bootstrap supporting values in the phylogenetic tree, we suggested that C1-part1 and C1-part2 should combine into a new subgenotype C1, C2-part1 should be new subgenotype C2, C2-part2 should be a new subgenotype C3, C? should be a new subgenotype C4, and C6 -- C7 should be combined into a new subgenotype C6 ([Fig. 2](#fig2){ref-type="fig"}C). Subgenotype C5 kept the original name. Among the six clades, C1--C4 are widely spread in Southeast and East Asia, C5 only in Southeast Asia, and C6 is mainly seen in Indonesia, Australia and scattered in South Korea ([Fig. 5](#fig5){ref-type="fig"}). Based on the new taxonomy, genetic variances over all sequence pairs in genotype C was given as 0.0418 to 0.0674 ([Table 12](#tbl12){ref-type="table"}).Table 11Estimates of evolutionary divergence over sequences pairs between tentative Genotype C.Table 11C2-*part1*C2-*part2*C1-*part1*C1-*part2*C?C6C7C5C2-*part1*C2-*part2*0.0418C1-*part1*0.04770.0511C1-*part2*0.04560.04870.0473C?0.04300.04660.04960.0488C60.05970.06430.06650.06470.0610C70.04840.05200.05620.05640.05010.0624C50.05900.06250.06490.06510.06140.07340.0609Fig. 5Geographical distributions of HBV Genotype C.Fig. 5Table 12Estimates of evolutionary divergence between subgenotypes of HBV genotype C.Table 12C1C2C3C4C5C6C1C20.0475C30.05090.0418C40.04950.04300.0466C50.06490.05900.06250.0614C60.05920.05130.05570.05320.0674

***Genotype D.*** Seven subgenotypes (D1-D7) used to be involved in genotype D, which consisted of 131 sequences ([Fig. 2](#fig2){ref-type="fig"}D). Geographical statistics showed that genotype D was prevalent in all continents except South America, but mainly in the Mediterranean area, the Middle East, and India ([Table 3](#tbl3){ref-type="table"}) \[[@bib10], [@bib39]\]. Further analysis showed that D4-D7 stains were only reported in one or two inter-cited studies, respectively ([Table 13](#tbl13){ref-type="table"}); genetic distance between D3 and D6 was only 0.0257 ([Table 14](#tbl14){ref-type="table"}); D4 and D7 possess a distinct geographic distribution.Table 13The major reports of subgenotype D4-D7.Table 13SubgenotypeReferencesD4Osiowy C, Larke B, Giles E. J Viral Hepat 2011; 18:e11-e19.D5Ghosh S, Banerjee P, RoyChoudhury A, *et al.* J Clin Microbiol 2010; 48:4063--4071.D6Utsumi T, Lusida MI, Yano Y, *et al.* J Clin Microbiol 2009; 47:1842--1847.D7Meldal BH, Moula NM, Barnes IH, *et al.* J Gen Virol 2009; 90:1622--1628.Table 14Estimates of evolutionary divergence over sequences pairs between tentative Genotype D.Table 14D4D7D2D1D3D6D5D4D70.0469D20.05300.0546D10.05280.05290.0392D30.04550.04940.04120.0401D60.04720.05090.04230.04170.0257D50.05490.05820.05670.05600.05090.0517

Based on the phylogenetic results, we adjusted clade D3/D6 to new subgenotype D3, D7 to new subgenotype D6 and the rest of the subgenotypes remained their old names. Although one of two strains in clade D? was believed to be a recombinant of D1/D7 \[[@bib40]\], the sequence successfully survived the recombinant elimination procedure. As a result, we strongly suggested D? should remain as an un-classifiable virus and be re-classified when more genotype D HBV sequences available in the future.

In the updated system of genotype D, D1-D3 has a worldwide distribution but common in the Mediterranean area, the Middle East and India, D4 is scatted across Oceania and Central and North America, D5 in India and D6 mainly in Africa ([Fig. 6](#fig6){ref-type="fig"} and [Table 15](#tbl15){ref-type="table"}).Fig. 6Geographical distributions of HBV Genotype D.Fig. 6Table 15Estimates of evolutionary divergence between subgenotypes of HBV genotype D.Table 15D1D2D3D4D5D6D1D20.0392D30.04220.0434D40.05280.05300.0478D50.05600.05670.05310.0549D60.05290.05460.05160.04690.0582

***Genotype E-H.*** Although the cases of these four types were mainly reported by few studies, each taxon of genotype E-H apparently formed an independent monophyletic branch in the phylogenetic tree ([Fig. 1](#fig1){ref-type="fig"} and [Table 16](#tbl16){ref-type="table"}). By referring to the results of previous reports, the geographical distribution of these HBV strains was updated in this study ([Table 17](#tbl17){ref-type="table"} and Figs. [7](#fig7){ref-type="fig"}, [8](#fig8){ref-type="fig"}, [9](#fig9){ref-type="fig"}, and [10](#fig10){ref-type="fig"}). As to genotyping, however, we tentatively support the present taxonomy that Genotype E, G, H presented independently with no subgenotypes and Genotype F was divided into four subgenotypes (F1--F4, Tables [3](#tbl3){ref-type="table"} and [18](#tbl18){ref-type="table"}), since the sequence information of those genotype/subgenotype are limited.Table 16The major reports of genotype E-H.Table 16GenotypeReferencesEBekondi C, Olinger CM, Boua N, *et al.* 2007; J Clin Virol 40:31--7.Garmiri P, Loua A, Haba N, *et al.* 2009; J Gen Virol 90:2442--51.Forbi JC, Vaughan G, Purdy MA, *et al.* 2010; PLoS One 5:e11615.Hübschen JM, Mbah PO, Forbi JC, *et al.* 2011; Clin Microbiol Infect 17:88--94.FDevesa M, Loureiro CL, Rivas Y, *et al.* 2008; J Med Virol 80:20--6.Torres C, Piñeiro y Leone FG, *et al.* 2011; Mol Phylogenet Evol 59:114--22.Sami H, Rizvi M, Azam M, *et al.* 2013; Adv Virol 2013:846849.GKato H, Orito E, Gish RG, *et al.* 2002; J Virol 76:6131--7.Bottecchia M, Souto FJ, Ó KM, *et al.* 2008; BMC Microbiol 8:11.Araujo NM, Araujo OC, Silva EM, *et al.* 2013; J Gen Virol 94:150--8.HArauz-Ruiz P, Norder H, Robertson BH, *et al.* 2002; J Gen Virol 83:2059--73.Tanaka Y, Sanchez LV, Sugiyama M, *et al.* 2008; Virology 376:408--15.Table 17Geographical distribution of Genotype E-H.Table 17GenotypePrevious reportsExtension in this studyEWest Coast of Africa, MadagascarArgentina and Colombia in South AmericaFrestricted to Central and South AmericaUSA: Alaska; Ireland; JapanGFrance, Germany, UK, Italy, USAArgentina, Belgium, Brasil, Mexico, Netherlands,\
TailandHNicaragua, Mexico and USAArgentina, Japan, TailandFig. 7Geographical distributions of HBV Genotype E.Fig. 7Fig. 8Geographical distributions of HBV Genotype F.Fig. 8Fig. 9Geographical distributions of HBV Genotype G.Fig. 9Fig. 10Geographical distributions of HBV Genotype H.Fig. 10Table 18Estimates of evolutionary divergence between subgenotypes of HBV genotype F.Table 18F1F2F3F4F1F20.0585F30.05620.0465F40.06360.05040.0503

There is no doubt that more cases of genotype E-H were expected, from which we can better understand evolutionary divergence in these groups.

***Genotype I.*** A previous study indicated that this genotype is derived from the recombination of the genotype C and an unknown genotype \[[@bib41]\]. In our analysis using RDP4, recombination is only supported in one of the sequences (FR714499) by all six algorithms, which has an unknown parent sequence from the genotype C. However, there is no evidence to support a scenario of recombination in the other three sequences (EU835240, FJ023667, and FR714496). These results imply that previous studies may have been misled by incomplete sampling ([Table 19](#tbl19){ref-type="table"}).Table 19The major reports of genotype I.Table 19SubgenotypeCountryRegionReferenceDetection of recombinationEU835240A/G/CIndiaSouth Asia*Unpublished*FJ023667I2LaosSoutheast AsiaOlinger CM, *et al.* Emerg Infect Dis 2008; 14:1777--1780.N/AFR714496X/CChinaEast AsiaFang ZL, *et al.* J Gen Virol 2011; 92:402--411.RDP2FR714499X/CChinaEast AsiaFang ZL, *et al.* J Gen Virol 2011; 92:402--411.RDP2[^6]

***Genotype J.*** A genetic variant that cannot be ignored was isolated from an 88-year-old Japanese patient with hepatocellular carcinoma. The only human case in the clade of non-human primates was believed to be a new genotype J (AB486012, [Fig. 1](#fig1){ref-type="fig"}) \[[@bib11]\]. Interestingly, the analysis against its allies seemed to suggest a cross-species transmission of non-human primate HBV to humans ([Table 20](#tbl20){ref-type="table"}). The novel genotype derived from Southwest Asia was enlightening and was only reported once so far. Given this, we tentatively support the validation of Genotype J.Table 20The source information of "Clade J".Table 20

4. Discussion {#sec4}
=============

We re-scaled the genotypes and subgenotypes frame of HBV via a Bayesian inference phylogenetic approach. There were totally 14 subgenotypes were either canceled or redefined. Based on the principle of reservation of old names, the monophyletic topology together with genetic variance were considered as the priority criteria of the re-classification.

The amount of HBV subgenotyping conclusion and nomenclature in the pervious studies are considered as inappropriate after our investigation in this study (Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}). At the same time, many works supported our analysis, such as, the phylogenetic position of F2 which was completely consistent with our OTU stains (DQ899142, DQ899144) \[[@bib42]\]; the cases of non-typical geographic distribution within clades were screened out by further demographic analysis (AB365453, FJ349225) \[[@bib38],[@bib43]\] and the researches focusing on origin of HBV constructed evolutionary trees with a topology identical to the ones in our study \[[@bib44], [@bib45]\].

Although we would like to insist that the only standard of genotype and subgenotype classification of HBV should be based on the monophyly of composed strains, we also calculate the genetic distance within or between HBV genotypes and subgenotypes. Systematic defects appeared when conducting HBV genotyping using 8% inter-subtypic divergence in genome-scale and 4% in S gene-scale. In this study, genetic differentiation ranges from 7.01% to 16.01% in genotype level, and the average distance reached 12.73% ([Table 21](#tbl21){ref-type="table"}), while the maximum variance is 5.16% and the minimum is 0.75% within groups ([Table 22](#tbl22){ref-type="table"}). This situation can interpret as the divergence between sequences is dynamically changed and the genotypes could be reassigned even, especially with the rapid growth of HBV genome data quantity. Even though genetic distances were estimated based on new HBV taxonomy, it does not mean that a new taxon should be assigned while values higher than the maximum in a certain group or several types should be integrated while lower than the maximum. Furthermore, since a few subgenotypes were deleted or redefined, it seems that more clinical correlations between HBV genome variation and treatment outcomes could be reviewed in an upgraded angle. Most importantly, we suggested that methods based on partitioned Bayesian Inference to reconstruct phylogeny applied in this study should be followed as a golden standard of HBV genotype/subgenotype classification in the future. With this, the representative sequences of OTUs, which represented each subgenotype of HBV were given in the supplementary data for further study ([Table 23](#tbl23){ref-type="table"}). Using phylogenetic analysis, a sequence can be located in a clade with proper classification and that subgenotype of HBV can be precisely medicated more effectively when more knowledge between genetic variation and clinical characteristics is available.Table 21Estimates of evolutionary divergence over sequences pairs between HBV genotypes.Table 21ABCDEFGHIB0.1031C0.09660.0965D0.10680.11480.1111E0.11090.12500.11850.0902F0.15390.15530.15020.15300.1549G0.12300.13870.13600.12510.11570.1594H0.15570.15730.15250.15220.15690.08650.1601I0.08480.09380.07010.10610.11180.14900.11980.1506J0.12770.12080.11800.13370.12740.15200.13640.15330.1145Table 22Estimates of evolutionary divergence over sequences pairs within HBV genotypes.Table 22ABCDEFGHIJ0.04710.05160.04050.04240.02950.05020.00750.01490.0463*n/c*[^7]Table 23Reference sequences recommended for phylogenetic analysis of HBV genotyping.Table 23Genotype AA1AB116082, AF418685, AF418689, FJ692566, AF418683, FJ692570, FJ692583, FJ692586, AB246317, JN182323, JN182326, AF297623, GU563545, AF297625, HQ646555, HQ646556, FJ692573, AY233275, AF297621, U87742, AY233290, AY233279A2AF143304, AF143306, DQ298163, GQ477469, EU859908, EU859927, GQ477500, FJ904411, EU859952A3AM184125, AB194952, HM363613, FN545825, FJ692555, FJ692599, FJ692609, FJ692608, FJ692611, FN545829, FN545840, FN545832, FN545839, FN545833, FN545837, GQ161813, FJ349296, FN545826Genotype BB1AB073847, AB300371, AB073849, AB073856, AB642101, AB073858, AB302095, AB106884, AB073853, AB642093B2AF461360, HM011504, EU939638, EU939660, GQ377638, HM011475, EU939636, FJ386648, EU579441, EU939675, JQ027313, EU547563, HM011466, FJ518811, FJ562262, GQ924630, DQ995804, FJ899790, EU939661B3AB219427, AB241116, GQ924640, AB219430, GQ924617, JQ027328, JQ429079, EU660230, GQ358140, GQ924628, GQ924639, GQ924641, DQ361535, EU331000, GQ358144, GQ358145, HM011487, GQ924621, GQ924635, AY800392, GQ924656, GQ358150B4GQ924626B5AB287320, DQ463799, DQ463802, JN792899, JN792901Genotype CC1AB074047, GQ924619, GQ924623, GQ924642, EU306686, JQ801522, AB117758, JQ801508, JN827425, JQ801518, DQ315782, JQ027326, JQ429078, EU498227, GQ358154, AB112063, AY167092, FJ904423, DQ089762, DQ089768, AY217376, AY217378, DQ089772, EU305542, AY217372, HM011486, DQ089790, DQ089776, DQ089785, DQ089780, EU872005, JQ040133, GQ377631, EU547559, FJ562300C2AB042285, AB205124, AB471851, D16665, AB042282, GQ475343, AB367405, GQ475326, AB367392, AB111112, AB111113, AB300369, GQ377593, FJ386645, AB367409, AB195948, AB367421, AB367413, AB367429, AY641563, EF137803, GQ475342, AB697510, AB298721, M38636, GQ475335, EU939547, FJ562320, FJ787490, EU939552, FJ386617, JQ040135, FJ386625, AB113877, B485809, EU589344, EU589346, FJ899767, FJ787487, FJ787488, EU939536, FJ386626, FJ899783, EU939539, GQ227695, J562273, GQ377563, FJ899775, B113878, AB250109, AB367420, AB367425, FJ899788, GQ372968, EU589340, FJ562317, FJ386622, EU939617, FJ386611, JF436919, AB367415, DQ993690, HM011479, AY206378, EU919165, HM011481, EU660225, EU660226, EU881995, EU919166, DQ089794, GQ475353, EU306717, EU306718, FJ032347, FJ032348, FJ787469, JQ040129, FJ899794, EU547562, FJ562326, JX504540, FJ562255, EU554540, EU939601, FJ899768, JQ027322, GQ377548, AY057947, EU560438, EU560439, EU939641, EU939643, EU787444, EU939541, EU939558, AB365452, AB697502, FJ032343, EU939564, EU939657, FJ562271, FJ787463, FJ562249, AF384372, EU560441, EU939655, FJ562293, FJ386677, AY220700, EU717213, FJ386594, EU939602, AB367428, FJ386580, FJ386651, FJ562336, EU939572, GQ377642, JQ040162, FJ386678, EU939574, EU939596, EU939659, FJ899770, JX026885, FJ562339, FJ562239, DQ986375, AF458665, EU796070, FJ787440, DQ089800, FJ787483, JQ040159, EU939568, FJ787456, FJ386640, FJ562248, FJ386612, FJ562302, EU939554, EU939580, FJ562241, HQ638218, FJ386586, FJ562245C3AB115417, AB115418, AY167091, AB367431, FJ562298, JQ027332, DQ089802, EU882006C4AB675675, AY206374, EU939624, AY206376, EU939625, GQ358158C5AP011100, GQ924657, GQ924620, JN827415C6AB048705, AB493838, AB493843, AP011103, AP011102, GQ358157, AP011106, AP011108, GU721029Genotype DD1AB188244, JN040787, AB270540, J904431, EU787440, GQ358159, EF103280, FJ904429, JF754626, JN040782, JN642133, JF754588, JF754622, JN642157, GU456684, JF754606, GU456648, AB270549, FJ904426, GU456677, DQ486023, X80924, EU787438, JN642136, JN040781, JN642128, JF754609, JF754617, JF754612, JN257195, GU456665, GU456674, GU456676, GU456678, JN040766, JN257214, GU456669, JN040760, JN040762, JN040768, JN040773, AB583681, GQ184322, AY236163, JN257211, N257212, JN257213, DQ304548, GQ183466, JN040752, JN040772, AY741798, GU456638, JN040818, GU456642, GU456644, GU456645, GU456647, GU456651, JN040820, JN040800, JN040812, JF754602, JF754632, JF754586, JF754611, JN257154, JN257158, JN257217, JN257207, JN642154, JF754608D2AB188241, GQ477453, GQ477456, AB205128, AY090452, JF754597, JF754621, FJ349206, GQ477454, JN642148, JN642162, JN642163, JN664944, GU456635, AB555500, AB555501, JN792905D3AB188243, AB270537, FJ692506, DQ329356, DQ486025, FJ349211, FJ349221, EU594435, FJ349213, GQ922000, JF754625, AB493848, EU921419, DQ315777, FJ562338, JX898692, EU939680, AB270538D4AB033559, FJ692533, GQ922004, GQ922005D5DQ315780, JN664929, GQ205381, JN664933, JN664934, JN664947, JN664923D6AM494716, FJ904397, FJ904428, FJ904439, FJ904436, FJ904414, FJ349207, FJ904400, FJ904425, FJ904433Genotype EEAB219533, DQ060829, GQ161805, EU239220, GQ161774, AB219534, HM363611, HM363583, FN545824Genotype FF1EU670261, HM590472, FJ589065F2DQ899142, DQ899144F3AB036905, FJ589068, DQ899150F4AB214516, JQ272888, AB365453, HE981178Genotype GGAB056516, AB375169Genotype HHAB275308Genotype IIEU835240, FJ023667, FR714496Genotype JJAB486012*non-human primatesnon-human primates*AB037928, AY781185, AY781181, AY781183, AJ131574, AY077736, HQ603058, HQ603059, FM209516, HQ603080, AJ131571, HQ603077, AY330915, FM209512, FM209513, AY330917, FM209514, AF242586, D00220, JQ664505, AJ131567, AM117396, AY330911, FJ798098

We believe that in the near future, after correctly genotyping and subgenotyping, more discoveries should be jointly carried out based on the symptoms, diagnosis, drug use, drug resistance feedbacks and prognosis of a certain type of hepatitis B. Only by combining molecular genetics with clinical practice, with the joint efforts of both laboratory scientists and physicians in departments, the work of genotyping can play a more profound role in the treatment of hepatitis B \[[@bib46], [@bib47], [@bib48], [@bib49]\].

In conclusion, based on over 4,000 sequences and partitioned Bayesian inference, this study updated the classification system of non-recombinant HBV. That is, phylogenetic analysis rather than sequence divergence should be used in genotyping or subgenotyping of HBV. Compared to previous taxonomy, fourteen subgenotypes (A5--A7, B5--B9, C2--C4, C7, and D6-D7) were revised in the new standard. Now the HBV is divided into ten genotypes (A-J) and 24 subgenotypes (A1--A3, B1--B5, C1--C6, D1--D6 and F1--F4; [Fig. 11](#fig11){ref-type="fig"}).Fig. 11Reference topology recommended for phylogenetic analysis of HBV genotyping. For limited space, the subgenotypes of genotype F \[F3(3 sequences), F4(2 sequences), F2(2 sequences) and F1(3 sequences) from the top down\] were unmarked in the figure.Fig. 11

As a significant change to the criterion that has existed for nearly 30 years, it will trigger a radical rethink about how the development of science promoting human cognition. Accompanied with subsequent clinical investigation, the right solutions will eventually be unraveled.
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